MENINGITIS
Clinical trials for MENINGITIS explained in plain language.
Never miss a new study
Get alerted when new MENINGITIS trials appear
Sign up with your email to follow new studies for MENINGITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Booster shot study aims to keep teens safe from meningitis b
⭐️ VACCINE ⭐️ CompletedThis study looked at whether a booster dose of the meningitis B vaccine (Bexsero) works well and is safe for healthy people aged 10 to 20. It included 312 participants who either got the vaccine as babies or had never received it. The goal was to see if the booster triggers a str…
Matched conditions: MENINGITIS
Phase: PHASE3 • Sponsor: GlaxoSmithKline • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:23 UTC
-
New meningitis vaccine shows promise for infants in phase 3 trial
⭐️ VACCINE ⭐️ CompletedThis study tested a new vaccine (NmCV-5) to protect infants against meningitis, a serious infection of the brain and spine. About 1,325 healthy infants in Mali received either the new vaccine or a standard one at 9 or 15 months old. The goal was to see if the new vaccine works as…
Matched conditions: MENINGITIS
Phase: PHASE3 • Sponsor: Emory University • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:02 UTC
-
Oral vs. needle: which stops Kids' seizures faster?
Symptom relief CompletedThis study tested whether giving midazolam in the mouth (buccal) works as well as a shot in the thigh (intramuscular) to stop seizures in children aged 6 months to 12 years. 90 children were randomly assigned to one of the two methods. The main goal was to see if seizures stopped…
Matched conditions: MENINGITIS
Phase: PHASE4 • Sponsor: Pakistan Air Force (PAF) Hospital Islamabad • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Scientists probe how meningitis vaccines spark immunity
Knowledge-focused CompletedThis study looked at how different meningococcal vaccines affect B cells, the white blood cells that produce antibodies. Researchers gave 20 healthy adults aged 30-70 either a polysaccharide or conjugate vaccine and then measured their B cell responses. The goal was to understand…
Matched conditions: MENINGITIS
Phase: PHASE4 • Sponsor: University of Oxford • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC